CLINICAL_TRIALS
trial_result
· 2025-08-11
Clinical Trial Update: Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease [Phase 2]
Summary
Phase 2 study evaluating INV-202 in patients with diabetic kidney disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Inversago Pharma Inc. | Conditions: Diabetic Kidney Disease | Phase 2 | Status: COMPLETED